Scott L. Burrows, CFO: Spyre Therapeutics SYRE Sell · Filed 10/02

Trade details

Type: Insider sale
Amount: $285,449.45
Shares · price: 3,071 sh · $92.95 a share
Held after: 79,991 sh
Stock: Spyre Therapeutics SYRE
Person: Scott L. BurrowsCFO
Trade date: 26/10/01
Filed: 26/10/02
Days to filing: 1 days

Sold 3.7% of holdings

Share of holding sold: 3.7%

Spyre Therapeutics trades, last 26 weeks

What else happened in Spyre Therapeutics around then

Filed or reported within 30 days of the trade day · 09/01~10/31

Scott L. Burrows's recent trades

Scott L. BurrowsCFO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$1.6M
17,500 sh
$1.6M
Filed 10/02
Traded 09/30
Scott L. BurrowsCFO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$193K
2,100 sh
$193K
Filed 10/02
Traded 10/01
Scott L. BurrowsCFO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$135.4K
1,500 sh
$135.4K
Filed 10/02
Traded 10/01
Scott L. BurrowsCFO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$53.4K
600 sh
$53.4K
Filed 10/02
Traded 10/01
Scott L. BurrowsCFO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$21.4K
229 sh
$21.4K
Filed 10/02
Traded 10/01

Scott L. Burrows, CFO — sold $285.4K of Spyre Therapeutics SYRE · 3.7% of holdings · 10b5-1 plan | Whalegun